-The Hindu New Delhi: As videos of the alleged police encounter of eight SIMI men who broke out of the Bhopal Central Jail continue to raise demands for a judicial probe, a series of Supreme Court judgments show that the law is heavily, even fatally, loaded against police officers found guilty of 'fake encounters'. One of the judgments even recommends death penalty to “trigger-happy” cops and compares them to Nazi war criminals...

-The Hindu The Global TB Report 2016, recently released, has revised the estimates for the tuberculosis (TB) burden in India upwards. The country has 27 per cent of the global burden of incident tuberculosis and 34 per cent of global TB deaths. For the year 2015, the updated estimate of incidence (new and relapse TB cases per year) is 2.8 million cases. India diagnosed and notified 1.7 million incident TB patients...

-The Hindu The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. Humanitarian aid organisation Médecins Sans Frontières (MSF) has warned India that the country will not remain ‘pharmacy of the developing world’ if the proposals in the Regional Comprehensive Economic Partnership agreement (RCEP) are adopted. The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in Auckland. MSF Access Campaign...

-The Hindu This month marks the introduction of the Sustainable Development Goals (SDGs), which aim to dramatically improve lives across the world by 2030. This month marks the introduction of the Sustainable Development Goals (SDGs), which aim to dramatically improve lives across the world by 2030. The SDGs will help countries frame their policies and strategies towards achieving these mutually agreed upon goals and targets. SDG 3, which aims to ensure good...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...